fluoromisonidazole Report issue

Small molecule Imaging Experimental
AACT MeSH PubChem

Active Ingredient History

NOW
  • Now
18F-FMISO or fluoromisonidazole is a radiopharmaceutical used for PET imaging of hypoxia. It consists of a 2-nitroimidazole molecule labelled with the positron-emitter fluorine-18.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Imaging: 18-fluorine
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Alternative names

1-(2-nitro-1-imidazolyl)-3-fluoro-2-propanol | 18f-fluoromisonidazole | 18f fmiso | 18f-fmiso | 18-f-miso | 18f miso | 18f-miso | 1-fluoro-2-hydroxypropyl-2-nitroimidazole | 1-fluoromisonidazole | (f-18) fluoromisonidazole | f-18-fluoromisonidazole | fluoromisonidazole | fluoromisonidazole, 18f-labeled | fluoromisonidazole, tritium-labeled | fluoronormethoxymisonidazole | fmiso | f-miso | ro 07-0741

Organizations (40)

Research & Development (40)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (24)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (24)


 

Brain Neoplasms (Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Colorectal Neoplasms (Phase 2)

Esophageal Neoplasms (Phase 1)

Glioblastoma (Phase 2)

Glioma (Phase 2)

Gliosarcoma (Phase 2)

Head and Neck Neoplasms (Phase 1/Phase 2)

Liver Cirrhosis (Phase 1)

Liver Neoplasms (Phase 2)

Lung Neoplasms (Phase 2)

Melanoma (Phase 2)

Nasopharyngeal Carcinoma (Phase 2/Phase 3)

Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 2)

Prostatic Neoplasms (Phase 2)

Sarcoma (Phase 2)

Skin Neoplasms (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Early Phase 1)

Triple Negative Breast Neoplasms (Early Phase 1)

Uterine Cervical Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 36
  • # of Trial Organizations: 40

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue